Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00235547 · ClinicalTrials.gov registry record · NA

Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
298
Enrollment target

NCT00235547 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 298 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00235547, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
298 participants
Enrollment target

Study Summary

This is a randomized, controlled trial investigating whether immediate versus standard, "Sunday Start", initiation of transdermal hormonal contraception (the patch) in post-abortion subjects can improve compliance and the continuation of contraception. Immediate initiation of the patch has been studied in women seeking contraception when they are not immediately post-abortion, and this "Quick Start" method has been shown to improve the continuation of the patch into a second month. The primary hypothesis of this study is that immediate initiation of the patch in post-abortal women will improve the continuation of contraception over delayed initiation on the first Sunday after an abortion.

Interventions

  • BEHAVIORAL timing of initiation of transdermal patch after an abortion

Trial Details

FieldValue
Enrollment Target 298 participants
Start Date 2005-08
Est. Completion 2012-12
Phase NA

What the Registry Record Tells You About NCT00235547

The ClinicalTrials.gov registry entry for NCT00235547 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which timing of initiation of transdermal patch after an abortion is the first listed.

NCT00235547 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00235547 about?

NCT00235547 is a clinical study titled "Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion". This is a randomized, controlled trial investigating whether immediate versus standard, "Sunday Start", initiation of transdermal hormonal contraception (the patch) in post-abortion subjects can improve compliance and the continuation of contraception. Immediate initiation of the patch has been stud...

What is the current status of trial NCT00235547?

This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2005-08. Estimated completion is 2012-12.

What interventions are being tested in trial NCT00235547?

The interventions under investigation include: timing of initiation of transdermal patch after an abortion (BEHAVIORAL).

Who is sponsoring clinical trial NCT00235547?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.